To evaluate clinical data from published trials on the use of intermittent androgen deprivation (IAD) therapy in patients with biochemical relapse after radical prostatectomy (RP).
We searched the Medline and Cochrane Library databases for literature published on IAD and biochemical progression after radical prostatectomy.